Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07495592 · ClinicalTrials.gov registry record · NA
The Acute Effects of Onnit Alpha Brain on Cognition and Mood States
A NA study, sponsored by Applied Science & Performance Institute.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT07495592 is a NA study that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 32 participants.
The verdict
NCT07495592, a NA study, has completed, sponsored by Applied Science & Performance Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this randomized, double-blind, placebo-controlled crossover study is to evaluate the efficacy of the acute effects of an investigational supplement (Alpha Brain or Alpha Brain 2.0) on improving cognitive performance, vigilance, and subjective mood in healthy adults compared to placebo during a period of acute sleep deprivation under conditions of controlled sleep deprivation.
Interventions
- DIETARY_SUPPLEMENT Alpha Brain proprietary cognitive dietary supplement
- DIETARY_SUPPLEMENT Alpha Brain 2.0 proprietary cognitive dietary supplement
- DIETARY_SUPPLEMENT Controlled Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2026-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07495592
The ClinicalTrials.gov registry entry for NCT07495592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Science & Performance Institute, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Alpha Brain proprietary cognitive dietary supplement is the first listed.
NCT07495592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07495592 about?
NCT07495592 is a clinical study titled "The Acute Effects of Onnit Alpha Brain on Cognition and Mood States". The purpose of this randomized, double-blind, placebo-controlled crossover study is to evaluate the efficacy of the acute effects of an investigational supplement (Alpha Brain or Alpha Brain 2.0) on improving cognitive performance, vigilance, and subjective mood in healthy adults compared to placebo...
What is the current status of trial NCT07495592?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2026-05-01. Estimated completion is 2026-06-26.
What interventions are being tested in trial NCT07495592?
The interventions under investigation include: Alpha Brain proprietary cognitive dietary supplement (DIETARY_SUPPLEMENT), Alpha Brain 2.0 proprietary cognitive dietary supplement (DIETARY_SUPPLEMENT), Controlled Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07495592?
This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.